Tapewire

Nasdaq · USD

SHC

Sotera Health Co

Export transactions ↓
Tapewire entity
3869
SEC CIK
0001822479
Parsed reports
171

Last 12 months

Inside the activity.

0 purchase rows · 18 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202506
Jan 202600
Feb 202600
Mar 202603
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202603
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 20, 2020 Filed Nov 24, 2020 23:49 UTC
Rutz Michael PPresident of Sterigenics
GrantStock Options · Derivative 111,801 $0.00 Strike: $23.00 $0.00
Disclosure

SEC source: 0000899243-20-032067 · doc4.xml · derivative · entry 2

Rutz Michael P · CIK 0001599220 · President of Sterigenics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,801

Underlying: Common Stock · 111,801 shares

Expires 2030-11-20

F3 · derivative.exercise_date: These options were granted on November 20, 2020, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

Read SEC document
November 20, 2020 Filed Nov 24, 2020 23:49 UTC
Rutz Michael PPresident of Sterigenics
GrantCommon Stock, $0.01 par value per share ("Common Stock") 26,086 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-032067 · doc4.xml · nonDerivative · entry 1

Rutz Michael P · CIK 0001599220 · President of Sterigenics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 621,043

F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of common stock, subject to vesting conditions. The RSUs vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

F2 · balance_after: Consists of 26,086 RSUs and 594,957 shares of Common Stock. 16,199 of the shares of Common Stock are vested, and 578,758 of the shares of Common Stock remain subject to vesting conditions. 20% of the shares of Common Stock will vest on May 13, 2021 (the one year anniversary of the date of grant), and the remaining shares will vest on a daily basis, pro rata through May 13, 2025. See Footnote #1 for information regarding the vesting of the RSUs.

Read SEC document
November 20, 2020 Filed Nov 24, 2020 23:45 UTC
Chen RuoxiDirector
GrantCommon Stock, $0.01 par value per share ("Common Stock") 5,869 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-032060 · doc4.xml · nonDerivative · entry 1

Chen Ruoxi · CIK 0001769832 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,869

F1 · shares: These securities consist of 5,869 Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.

Read SEC document
November 20, 2020 Filed Nov 24, 2020 23:48 UTC
Klee Ann R.Director
GrantCommon Stock, $0.01 par value per share ("Common Stock") 5,869 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-032065 · doc4.xml · nonDerivative · entry 1

Klee Ann R. · CIK 0001796076 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,794

F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.

F2 · balance_after: Consists of 5,869 RSUs and 50,925 shares of Common Stock, including 16,199 shares of vested Common Stock and 34,726 shares of unvested Common Stock. 20% of the unvested shares of Common Stock will vest on May 27, 2021 (the one year anniversary of the date of grant), and the remaining unvested shares will vest on a daily basis pro rata thereafter, through May 27, 2025.

Read SEC document
November 20, 2020 Filed Nov 25, 2020 00:02 UTC
Leffler Scott J.CFO and Treasurer
GrantStock Options · Derivative 223,602 $0.00 Strike: $23.00 $0.00
Disclosure

SEC source: 0000899243-20-032083 · doc4.xml · derivative · entry 3

Leffler Scott J. · CIK 0001832406 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 223,602

Underlying: Common Stock · 223,602 shares

Expires 2030-11-20

F5 · derivative.exercise_date: These options were granted on November 20, 2020, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

Read SEC document
November 20, 2020 Filed Nov 25, 2020 00:02 UTC
Leffler Scott J.CFO and Treasurer
GrantCommon Stock, $0.01 par value per share ("Common Stock") 52,173 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-032083 · doc4.xml · nonDerivative · entry 1

Leffler Scott J. · CIK 0001832406 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 820,426

F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of common stock, subject to vesting conditions. The RSUs vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

F2 · balance_after: Consists of 768,253 shares of Common Stock (see Footnote #4 for information regarding the vesting of the Common Stock) and 52,173 RSUs.

Read SEC document
November 20, 2020 Filed Nov 25, 2020 00:00 UTC GrantCommon Stock, $0.01 par value per share ("Common Stock") 5,869 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-032082 · doc4.xml · nonDerivative · entry 1

CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,869

F1 · shares: These securities consist of 5,869 Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.

Read SEC document
November 20, 2020 Filed Nov 24, 2020 23:56 UTC
Petras Michael B. Jr.Director · Chairman & CEO
GrantStock Options · Derivative 1,118,012 $0.00 Strike: $23.00 $0.00
Disclosure

SEC source: 0000899243-20-032076 · doc4.xml · derivative · entry 4

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,118,012

Underlying: Common Stock · 1,118,012 shares

Expires 2030-11-20

F3 · derivative.exercise_date: These options were granted on November 20, 2020, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

Read SEC document
November 20, 2020 Filed Nov 24, 2020 23:56 UTC
Petras Michael B. Jr.Director · Chairman & CEO
GrantCommon Stock, $0.01 par value per share ("Common Stock") 260,869 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-032076 · doc4.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,869

F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of common stock, subject to vesting conditions. The RSUs vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.